These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17260021)

  • 1. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer.
    Kohonen-Corish MR; Sigglekow ND; Susanto J; Chapuis PH; Bokey EL; Dent OF; Chan C; Lin BP; Seng TJ; Laird PW; Young J; Leggett BA; Jass JR; Sutherland RL
    Oncogene; 2007 Jun; 26(30):4435-41. PubMed ID: 17260021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
    Young J; Jass JR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.
    Naghibalhossaini F; Hosseini HM; Mokarram P; Zamani M
    Pathol Oncol Res; 2011 Dec; 17(4):819-25. PubMed ID: 21455633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
    Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
    Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
    Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia.
    Bai AH; Tong JH; To KF; Chan MW; Man EP; Lo KW; Lee JF; Sung JJ; Leung WK
    Int J Cancer; 2004 Dec; 112(5):846-53. PubMed ID: 15386372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
    Fukuyama R; Niculaita R; Ng KP; Obusez E; Sanchez J; Kalady M; Aung PP; Casey G; Sizemore N
    Oncogene; 2008 Oct; 27(46):6044-55. PubMed ID: 18591935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.
    Loh K; Chia JA; Greco S; Cozzi SJ; Buttenshaw RL; Bond CE; Simms LA; Pike T; Young JP; Jass JR; Spring KJ; Leggett BA; Whitehall VL
    Genes Chromosomes Cancer; 2008 Jun; 47(6):449-60. PubMed ID: 18311777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.
    Kriegl L; Neumann J; Vieth M; Greten FR; Reu S; Jung A; Kirchner T
    Mod Pathol; 2011 Jul; 24(7):1015-22. PubMed ID: 21423154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colorectal serrated lesions: current insight on their role in colorectal carcinogenesis].
    Mäkinen M
    Duodecim; 2010; 126(17):2002-11. PubMed ID: 21053517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
    Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
    Messick CA; Church J; Casey G; Kalady MF
    Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.